Cells make their largest decisions at a few regulatory hubs: AMPK, which senses energy; mTOR, which decides whether to grow; p53, which guards the genome; and NF-κB, which coordinates inflammation and immunity. These hubs regulate one another in a web rather than a chain of command, but they have something in common. AMPK reads the ratio of AMP and ADP to ATP directly. mTOR checks the supply of S-adenosylmethionine through a dedicated sensor. p53 carries acetyl, methyl, ubiqu

At first glance, p53 and mTOR appear to represent two very different strategies for regulating cellular behavior. p53 is traditionally viewed as the guardian of the genome, responding to DNA damage by determining whether a cell should pause, repair itself, enter senescence, or die. mTOR is regarded as the master regulator of growth, integrating nutrient availability, energy status, growth factors, oxygen, and mechanical signals to determine whether the cell should build new p

For many years, p53 was viewed as the cell's principal regulator of apoptosis. Its function appeared relatively straightforward. DNA damage activated p53, p53 stopped the cell cycle while repair occurred, and if the damage proved too severe, p53 activated genes such as BAX, PUMA, and NOXA that caused the mitochondria to release cytochrome c and initiate apoptotic cell death. This picture established p53 as the "guardian of the genome," but it also suggested that its decision-

p53 is widely known as the “guardian of the genome,” and it is the single most commonly altered protein in human cancer. Yet the modern p53 molecule did not appear all at once with the rise of multicellular animals. Over more than a billion years, it evolved from a simple environmental stress sensor with an on/off switch into one of the most sophisticated information-processing molecules in living cells — a system that gathers signals from dozens of independent pathways and s